Intermolecular provides high productivity combinatorial technology products and services for a wide range of industries. The Company's HPC platform, which consists of its Tempus processing tools, unique, automated characterization methods, and its Informatics analysis software, is purpose-built for research and development using combinatorial process systems in concert with established CVD, physical vapor deposition, and atomic layer deposition methods. Combinatorial processing is a methodology for experimentation, discovery, and development that employs parallel and other high-throughput experimentation, which allows R&D experimentation to be performed at speeds up to 100 times faster than conventional R&D platforms, which are optimized for manufacturing rather than for R&D.

Employee Rating

3.2More
TypePublic
HQSan Jose, US
Founded2004
Size (employees)145 (est)
Websiteintermolecular.com
Intermolecular was founded in 2004 and is headquartered in San Jose, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Intermolecular

Tony Chiang

Tony Chiang

CTO

Intermolecular Office Locations

Intermolecular has an office in San Jose
San Jose, US (HQ)
3011 N 1st St
Show all (1)
Report incorrect company information

Intermolecular Financials and Metrics

Intermolecular Revenue

Embed Graph
View revenue for all periods
Intermolecular's revenue was reported to be $47.30 m in FY, 2016 which is a 4.4% increase from the previous period.
USD

Revenue (Q3, 2018)

7.9m

Gross profit (Q3, 2018)

5.8m

Gross profit margin (Q3, 2018), %

73.8%

Net income (Q3, 2018)

(686.0k)

EBIT (Q3, 2018)

(932.0k)

Market capitalization (22-Jan-2019)

57.2m

Closing stock price (22-Jan-2019)

1.2

Cash (30-Sep-2018)

6.9m
Intermolecular's current market capitalization is $57.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

67.4m47.7m45.3m47.3m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

32.5m24.7m19.3m15.8m

Gross profit

34.9m23.0m26.0m31.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

17.7m15.9m9.9m10.9m9.8m11.0m11.5m14.5m11.7m10.6m9.9m8.1m8.6m9.7m9.8m7.9m

Cost of goods sold

9.1m6.6m5.6m6.2m5.5m4.6m5.0m4.8m4.1m3.5m3.0m2.5m2.9m3.4m2.9m2.1m

Gross profit

8.7m9.3m4.3m4.7m4.4m6.4m6.5m9.7m7.6m7.1m7.0m5.5m5.7m6.3m6.9m5.8m

Gross profit Margin, %

49%59%43%43%44%58%56%67%65%67%70%69%67%65%71%74%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

72.1m21.8m11.7m5.8m6.1m

Accounts Receivable

Inventories

2.2m1.8m1.6m1.4m

Current Assets

81.4m72.2m43.1m32.3m30.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

74.3m72.3m41.8m22.1m25.6m14.4m3.3m17.1m16.4m9.7m7.6m6.5m9.9m4.4m4.3m6.9m

Accounts Receivable

2.8m3.5m4.2m1.9m3.3m

Inventories

7.5m7.3m7.4m

Current Assets

87.8m79.3m76.0m74.0m68.9m66.6m43.5m35.9m37.9m34.5m32.6m25.5m29.2m32.4m32.7m34.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(8.8m)(21.8m)(21.0m)(15.4m)(10.4m)

Depreciation and Amortization

9.4m10.9m10.7m

Inventories

(1.3m)1.6m(319.0k)

Accounts Payable

747.0k(635.0k)(24.0k)(493.0k)592.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(2.2m)(3.9m)(10.7m)(15.7m)(7.0m)(12.7m)(5.8m)(1.7m)(4.0m)(12.4m)(5.8m)(8.7m)(10.5m)(623.0k)(127.0k)(814.0k)

Depreciation and Amortization

2.5m5.2m2.5m5.2m2.0m

Inventories

(711.0k)(497.0k)50.0k445.0k585.0k

Accounts Payable

(833.0k)(492.0k)(1.2m)(284.0k)144.0k1.8m(655.0k)786.0k(453.0k)746.0k743.0k688.0k(554.0k)(750.0k)(304.0k)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Intermolecular Online and Social Media Presence

Embed Graph
Report incorrect company information

Intermolecular News and Updates

Intermolecular Reports Third Quarter and Nine Month 2018 Financial Results

SAN JOSE, Calif., Nov. 6, 2018 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for the third quarter and nine months ended September 30, 2018. Q3 2018 Financial and Operational Highlights Revenue of $7.9...

Intermolecular Board of Directors Authorizes $10 Million Share Repurchase Program

SAN JOSE, Calif., Nov. 6, 2018 /PRNewswire/ -- The board of directors of Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, has approved a share repurchase program pursuant to which Intermolecular may repurchase up to $10 million of shares of its...
Report incorrect company information

Intermolecular Company Life and Culture

Report incorrect company information

Intermolecular Frequently Asked Questions

  • When was Intermolecular founded?

    Intermolecular was founded in 2004.

  • Who are Intermolecular key executives?

    Intermolecular's key executives are Tony Chiang.

  • How many employees does Intermolecular have?

    Intermolecular has 145 employees.

  • What is Intermolecular revenue?

    Latest Intermolecular annual revenue is $47.3 m.

  • What is Intermolecular revenue per employee?

    Latest Intermolecular revenue per employee is $326.2 k.

  • Who are Intermolecular competitors?

    Competitors of Intermolecular include Novarials Corporation, Grolltex and Eigenphase Technologies.

  • Where is Intermolecular headquarters?

    Intermolecular headquarters is located at 3011 N 1st St, San Jose.

  • Where are Intermolecular offices?

    Intermolecular has an office in San Jose.

  • How many offices does Intermolecular have?

    Intermolecular has 1 office.